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INTRODUCTION
Dengue fever is one of the most important
arthropod-borne viruses transmitted by Aedes
aegypti in tropical countries. Dengue virus be-
longs to the Flaviviridae family and includes four
antigenic serotypes (DEN-1, DEN-2, DEN-3 and
DEN-4) which are responsible for the disease.
The clinical patterns range from mild febrile ill-
ness (fever, muscular pain, headaches and di-
gestive disorders) to severe forms of infection
(haemorrhage, shock syndrome, encephalitis)
which may lead to death. In the absence of vac-
cines and specific treatments, prevention is pri-
marily recommended by integrated vector con-
trol strategies (WHO, 1997).
In order to search for new antiviral drugs,
bioactive metabolites isolated from marine inver-
tebrates living in New-Caledonian waters were
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Abstract. The virucidal and antiviral photoactivities of three compounds, hypericin, tetrabromohypericin
and gymnochrome B, were evaluated against dengue viruses. All the three products were active,
and both the virucidal and antiviral activities were enhanced by light. Gymnochrome B was more
potent than hypericin and tetrabromohypericin. The presence of the side chains on the hypericin
core of gymnochromes appears to be beneficial for both virucidal and antiviral activities. This en-
hanced activity is likely to be linked to a complementary mechanism independent of photoactivation.
investigated. Antiviral properties of gymno-
chromes against dengue viruses were previously
reported (Laille et al, 1998). Gymnochromes are
brominated compounds with an hypericin core
obtained from a fossil crinoïd Gymnochrinus
richeri (De Riccardis et al, 1991). Hypericin and
pseudohypericin are known for their high po-
tency against retroviruses (Meruelo et al, 1988).
The virucidal and antiviral photoactivities of hy-
pericin were first demonstrated on inactivated
murine cytomegalovirus, Sindbis virus and hu-
man immunodeficiency virus type 1 (Hudson et
al, 1991). Photosensitization of hypericin is also
required for the inactivation of Equine Infectious
Anemia Virus (Carpenter and Kraus, 1991). Fur-
thermore, Hudson et al (1999) demonstrated the
effect of light exposure on the antiviral activities
of hypericin and its brominated derivatives
against both Herpes simplex and Influenza vi-
ruses. These compounds have extended-elec-
tron systems which are responsible for singlet
oxygen production upon photoexcitation with
visible light. Similarly (Sauviat et al, 2001) showed
that photoexcitation of gymnochrome A blocked
the background K+ current in frog atrial heart
muscle and altered transmembrane currents.
The aim of this study was to compare the viru-
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cidal and antiviral photoactivities of hypericin,
tetrabromohypericin and gymnochrome B on
dengue virus.
MATERIALS AND METHODS
Chemicals
Chemicals were obtained from Sigma-
Aldrich (analytical grade). Hypericin was pur-
chased from Extrasynthese (Genay, France).
Tetrabromohypericin was obtained from hyperi-
cin as follows (Itaya  et al, 1999): a solution of
Br2 in acetic acid (three times 15 µl, 90 µmoles)
was added to a stirred solution of hypericin (19.8
µmoles) and sodium acetate AcONa (62 µmoles)
in 1 ml acetic acid at room temperature, pro-
tected from light. The reaction was monitored
by electrospray ionization mass spectra (ESI-MS)
until the bromination was completed to the
tetrabromine derivative after 75 min, using an
esquire-liquid chromatography apparatus in
negative mode: [M-H], 79Br, hypericin: 503.2 mu,
Br-hypericin: 581.0 mu, Br2-hypericin: 659.0 mu,
Br3-hypericin: 736.8 mu, Br4-hypericin: 814.8
mu. The resulting purple red solution was diluted
in 40 ml of chloroform and the solution was
washed with water. The chloroform solution was
dried over anhydrous sodium sulfate and the
solvent vacuum-evaporated. The 2,5,9,12-
tetrabromohypericin was obtained as a dark solid
(7 mg, 43% overall yield) and controlled by thin
layer chromatography and ESI-MS in negative
mode. UV-Vis spectrum using a Beckman DU-
600 spectrophotometer (λmax in MeOH: 291,
327, 391, 483, 551, 594) was consistent with
Falk’s data (Falk and Schmitzberger, 1993).
Gymnochrome B was isolated from the deep
water stalked fossil crinoïd Gymnochrinus richeri
collected on the seamounts of the Norfolk Ridge
and pur i f ied as previously descr ibed (De
Riccardis et al, 1991). The compounds were dis-
solved in dimethyl sulfoxide (DMSO), and diluted
in culture medium to obtain stock solutions at 1
mg/ml and up to a 1% maximum final DMSO
concentration and stored at 4ºC in the dark. The
tested doses ranged from 50 to 0.001 µg/ml.
Virus stocks
DEN-4 (H-241 prototype strain) and DEN-
2 (New Guinea C prototype strain) virus stocks
were prepared using infected brains of suckling
mice, and titrated using serial dilutions of virus
stock by plaque assays using Porcine PS cell
layers. Titration plaques were counted 5 days
post-inoculation, preceded by gentian violet col-
oration. The concentration of the viral suspen-
sions was expressed as the number of Plaque
Forming Units (PFU) per mL. Adequate aliquots
of virus suspensions were stored at -80ºC. DEN-
1 (strain 16007), DEN-2 (strain 16681), DEN-3
(strain 16562), DEN-4 (strain D4/1036) and Japa-
nese Encephalitis Virus (Beijing strain) were also
prepared and titrated using LLCMK2 cells be-
fore and after tests with the compounds in Thai-
land (Russel et al, 1967).
Virucidal and antiviral assays
A previously described method with slight
modifications was used to evaluate the virucidal
and antiviral activities of the products by plaque
reduction assays using PS cells in 24-well plates
for all virus strains tested. Briefly the compounds
were tested using ten-fold dilutions in the pres-
ence of 50-100 PFU. For the virucidal assays, the
virus-tested compound mixture contained in a
test tube was incubated for 30 minutes at 37ºC
prior to inoculation. The gelled 3% carboxym-
ethylcellulose culture medium was poured 1 h
post-inoculation. In antiviral assays, the tested
compound was diluted in the carboxymethylcel-
lulose medium and applied 1 hour post-inocula-
tion with the virus. Plaques were counted 5 days
post-inoculation by staining the cells with gen-
tian violet and the percentage of plaque reduc-
tion calculated versus the 0% reduction control.
For the virucidal experiments conducted with
light, an irradiation period of 30 min with a 60
watt bulb (6,750 lux) placed at a distance of 30
cm, was applied to the virus-gymnochrome
mixture prior to inoculation. For the antiviral ex-
periments conducted in the absence of light, the
plates were directly incubated after depositing
the tested compounds. In the presence of light,
the plates were irradiated for 30 minutes before
incubation.
Stastistical analysis
For each concentration, the mean value of
the percentage of inhibition was calculated.
Curves of the percentage of inhibition versus the
log of the concentration of the tested products
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for both assays (virucidal and antiviral) with or
without light were then plotted. In the case of
linearity according to the F-test, the dose of
product able to reduce 50% of the number of
foci was calculated by interpolation. Such a dose
was expressed as the 50% Effective Dose (ED50).
For either virucidal or antiviral effects, the com-
parison of the overall level of potency between
the three products tested at different concen-
trations and in the absence light was carried out
by the analysis of covariance (ANCOVA). The
difference between the three products was as-
sessed upon the F value with a risk <0.05. A
similar comparison was performed for assays
conducted in the presence of light. Furthermore,
the potency of each product for either virucidal
or antiviral effects “without light” versus “with
light” was compared using the ANCOVA analy-
sis according to the F value with a risk < 0.05.
RESULTS
Chemical structure of the tested compounds
The structures of hypericin, tetrabromo-
hypericin, gymnochrome A and gymnochrome
B are depicted in Fig 1. Gymnochrome A, whose
molecule possesses four bromine atoms, is
closer to tetrabromohypericin than gymno-
chrome B, which possesses three bromine at-
oms. Due to its limited availability, gymnochrome
A could not be used for this study. However,
preliminary tests did not show significant differ-
ences between their antiviral activities.
Comparison of either virucidal or antiviral ef-
fects of the three products in the absence of
light
The results expressed as their ED50 values
are summarized in Table 1. For either virucidal
or antiviral DEN-4 assays without light, the three
products demonstrated significant differences in
their potency levels (p=0.001). These activities
were log dose-dependent upon a linear regres-
sion curve (Fig 2a and 2b). The decreasing po-
tency of the virucidal effects was in the follow-
ing order: gymnochrome B (ED50 = 0.21 nM/ml),
hypericin (ED50 = 6.2 nM/ml) and tetrabro-
mohypericin (ED50 = 14 nM/ml). For antiviral ef-
fects, the order was the same: gymnochrome B
(ED50 = 0.56 nM/ml), hypericin (20 < ED50 < 99.4
nM/ml) and tetrabromohypericin (ED50 > 61 nM/
ml).
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Fig 1–Structure of gymnochrome.
Table1
Virucidal and antiviral effects against dengue-4 viruses of the tested products with and
without light.
With light Without light
Product Virucidal Antiviral    Virucidal     Antiviral
ED50 (nM/ml) ED50 (nM/ml)
Hypericin 1.8 (13) 0.6 (8)   6.2 (12)   20<ED50<99.4 (12)
Tetrabromohypericin 2.8 (10) 3.7 (13)    14 (10) > 61 (13)
Gymnochrome B 0.042 (30) 0.029 (24) 0.21 (29) 0.56 (29)
ED50 = 50% Effective doses; ( ) = number of duplicate assays at concentrations ranging between 0.001 and 50
µg/ml
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Comparison of either the virucidal or the antivi-
ral effects of the three products in the presence
of light
For either virucidal or antiviral DEN-4 as-
says with light, the three products showed sig-
nificantly different potency levels (p=0.001) (Table
1). These activities were log dose-dependent
upon a linear regression curve (Fig 2a and 2b).
The virucidal potency are listed in decreasing
order as follows: gymnochrome B (ED50 = 0.042
nM/ml), hypericin (ED50 = 1.8 nM/ml) and
tetrabromohypericin (ED50 = 2.8 nM/ml). The
same pattern of relative potency was observed
in the antiviral assays: gymnochrome B (ED50 =
0.029 nM/ml), hypericin (ED50 = 0.6 nM/ml) and
tetrabromohypericin (ED50 = 3.7 nM/ml).
Influence of light
Light increased the virucidal potency of
each of the three products by a factor of 3.5,
4.9 and 5.2, for hypericin, tetrabromohypericin
and gymnochrome B, respectively (ED50 values).
The antiviral effects were much higher in the
presence of light for gymnochrome B, whose
ED50 decreased by 19.3 times.
Mechanism of action
Hypericin derivatives showed virucidal and
antiviral activities against DEN-4 prototype strain
(H-241). In addition, similar effects were ob-
served with the DEN-2 prototype strain (New
Guinea C), Thai Dengue virus strains (see virus
stocks) and another flavivirus, the Japanese
Encephalitis Virus (data not shown). The virucidal
activity of gymnochrome was not observed in
experiments previously carried out in our labo-
ratory (Laille et al, 1998).  because the effect of
light was not investigated.
DISCUSSION
As reported by Hudson et al (1999), for Her-
pes simplex and Influenza viruses, the overall
activity of the three compounds (hypericin,
tetrabromohypericin and gymnochrome B)
against dengue virus was potentialized upon
exposure to light, especially for gymnochrome
B in both virucidal and antiviral assays. As for
Herpes simplex and Influenza viruses, the least
active product against the dengue virus was
tetrabromohypericin. Gymnochrome B was the
most active product against the dengue virus,
while it had the same potency as hypericin and
dibromohypericin against Herpes simplex vi-
ruses. These observations point out the role of
the gymnochrome side chains and their activi-
ties against the dengue virus, whereas the Her-
pes simplex and Influenza viruses are probably
not sensitive to products with this chemical
structure. Possible differences in the mechanism
of action of these products against viruses have
to be considered.
Studies of the structure-activity relationship
of hypericin and related analogues have been
described by Cohen et al (1996). Antiviral activ-
ity against Herpes simplex viruses was negatively
correlated with the level of substitution of chlo-
rine in the hypericin structure in position 7 (7,7'-
dichlorohypericin). Studies of the antiretroviral
activities of quinones, hypericin and pseudohy-
pericin against the equine infectious anemia vi-
rus (a retrovirus which has been used as a model
for HIV), showed that the complete ring struc-
ture of hypericin is required for photoactivation-
dependant antiviral activity (Kraus et al, 1990).
For some synthetic 1,4-phenanthrenequinones,
the antiretroviral activity occurs through a
mechanism independent of photoactivation
(Kraus et al, 2000; Fehr et al, 1994) suggesting
the possibility of a light-independent mechanism.
They have shown that the oxygen singlet does
not play a major role in the antiviral activity of
hypericin.
In our experiments, the differences between
the activities of hypericin and gymnochrome B
were not due to the photophysical aspects. The
fact that they have the same absorption spectra
with a strong maximum at approximately 590
nm, and that the differences between their ac-
tivities exist in the absence of light, suggests
that the side chains are responsible of an addi-
tional effect, or an enhanced photoactive effect
of the hypericin core.
This result does not depend on bromine
substitution. In order to assess whether the ob-
served activities are specific or general toxic ef-
fects, we calculated an experimental selectivity
index (SI), defined as the ratio of cytotoxicity to
antiviral or virucidal activity. During the antiviral
experiments, in the absence of light exposure,
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gymnochrome B showed cytotoxic effects on
porcine cells at a concentration of 50 µg/ml (58
nM/ml); upon light exposure, the cytotoxic ef-
fects were observed at a concentration of 1 µg/
mL (1.2 nM/ml). Therefore the SI was approxi-
mately 100 without light and 40 with light. For
the virucidal experiments without or with light
exposure, cytotoxicity was absent at 50 µg/ml,
consequently the SI was higher (superior to 273
and 1404, respectively) than that for the antivi-
ral experiments. For the antiviral experiments,
light favors the cytotoxic effect to a greater ex-
tent than the antiviral activity.
In summary, gymnochrome B exhibits po-
tent virucidal and antiviral activities due both to
a photoactivity of its brominated hypericin core
and to another mechanism linked to the side
chains.
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